Edition:
India

Cipla Ltd (CIPL.BO)

CIPL.BO on Bombay Stock Exchange

648.15INR
17 Aug 2018
Change (% chg)

Rs0.75 (+0.12%)
Prev Close
Rs647.40
Open
Rs651.80
Day's High
Rs655.00
Day's Low
Rs645.00
Volume
112,530
Avg. Vol
209,117
52-wk High
Rs663.00
52-wk Low
Rs508.10

Select another date:

Thu, Aug 9 2018

BUZZ-India's Cipla hits near 9-mth high on Q1 profit beat

** India's third-largest drugmaker by market capitalisation Cipla Ltd's shares rise as much as 4.7 pct to 662.5 rupees, its highest since Nov 2017

Cipla first-quarter profit trumps estimates on strong domestic growth

Indian drugmaker Cipla Ltd posted quarterly profit well above analysts' expectations, helped by strong growth in the domestic market.

UPDATE 1-India's Cipla Q1 profit trumps estimates on strong domestic growth

* India revenue up 22 pct (Adds detail, share movement, appointment of global COO)

India's Cipla Q1 profit trumps estimates

Aug 8 Cipla Ltd, India's third-largest drugmaker by market capitalisation, posted on Wednesday a more than 10 percent rise in its first-quarter profit, well above analysts' expectations.

MEDIA-India's Cipla plans acquisitions to enter new therapies, boost Africa business - Business Standard

- Note: Reuters has not verified this story and does not vouch for its accuracy

BUZZ-Weak Q1 expected for Cadila, Lupin; improving trends for Cipla, Sun - Credit Suisse

** April-June quarter should be weak for Cadila Healthcare Ltd and Lupin Ltd with sharp declines in U.S. sales q-o-q - Credit Suisse (CS)

BUZZ-India's Cipla posts biggest intraday gain in over 3 months on Q4 profit

** Cipla Ltd rises as much as 7.8 pct to 564.90 rupees - posts biggest intraday pct gain since Feb 8

Cipla posts fourth quarter profit, misses estimates

Cipla Ltd, India's second-biggest drugmaker by market capitalization, posted a fourth-quarter profit on Tuesday, but missed street estimates.

UPDATE 1-India's Cipla posts Q4 profit, misses estimates

May 22 Cipla Ltd, India's second-biggest drugmaker by market capitalization, posted a fourth-quarter profit on Tuesday, but missed street estimates.

India's Cipla posts Q4 profit

May 22 Cipla Ltd, India's second-biggest drugmaker by market capitalization, posted a fourth-quarter profit on Tuesday, but missed analysts' estimates.

Select another date: